Carregant...
Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study
Methods: In a non-randomised, prospective, open label study, 24 patients (mean age 10.2 years, range 3.3–16.3) with polyarticular JIA were treated with either infliximab (n=14) or etanercept (n=10). The patients had had active polyarthritis for at least one year and standard treatment had failed. An...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754468/ https://ncbi.nlm.nih.gov/pubmed/12594111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.3.245 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|